NR1H4 and type 2 diabetes mellitus: In the db/db mouse model of T2DM characterized by IR, treatment with BAs or specific agonists for FXR significantly improved insulin sensitivity and effectively reduced blood glucose levels thereby ameliorating diabetic symptoms (183).